Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,497.09 79.56 0.55%
TOPIX 1,169.88 3.29 0.28%
HANG SENG 22,760.24 64.23 0.28%

Filing of the 2012 U.S. Form 20-F and French “Document de Référence” containing the Annual Financial Report


PR Newswire/Les Echos/

PRESS RELEASE

Filing of the 2012 U.S. Form 20-F and French " Document de Référence "

containing the Annual Financial Report

Paris, France - March 8, 2013 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its "Document de Référence" containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).

These documents are available on the "Investors" page of the company's corporate website (www.sanofi.com) under the heading "Regulated Information in France." In addition, the Form 20-F is available on the website of the SEC (www.sec.gov), and the "Document de Référence" is available on the website of the AMF (www.amf-france.org). Shareholders may receive a hard copy of these documents, each of which contains our complete audited financial statements, free of charge, upon request.

About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contacts:

Media Relations Investor Relations Jean-Marc Podvin Sébastien Martel Tel.: + (33) 1 53 77 46 46 Tel.: + (33) 1 53 77 45 45 mr@sanofi.comir@sanofi.com

The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.

-0- Mar/11/2013 07:11 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement